Our top pick for
CNO Financial Group, Inc is an insurance-life business based in the US. CNO Financial Group shares (CNO) are listed on the NYSE and all prices are listed in US Dollars. CNO Financial Group employs 3,400 staff and has a trailing 12-month revenue of around USD$3.8 billion.
|52-week range||USD$8.6215 - USD$24.68|
|50-day moving average||USD$22.9173|
|200-day moving average||USD$19.9515|
|Wall St. target price||USD$24.33|
|Dividend yield||USD$0.46 (1.89%)|
|Earnings per share (TTM)||USD$2.11|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing CNO Financial Group stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of CNO Financial Group's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
CNO Financial Group's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 11x. In other words, CNO Financial Group shares trade at around 11x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
CNO Financial Group's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.58. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into CNO Financial Group's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
CNO Financial Group's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$744.8 million.
The EBITDA is a measure of a CNO Financial Group's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$3.8 billion|
|Operating margin TTM||11.86%|
|Gross profit TTM||USD$1.7 billion|
|Return on assets TTM||0.82%|
|Return on equity TTM||5.94%|
|Market capitalisation||USD$3.3 billion|
TTM: trailing 12 months
There are currently 3.4 million CNO Financial Group shares held short by investors – that's known as CNO Financial Group's "short interest". This figure is 0.1% down from 3.4 million last month.
There are a few different ways that this level of interest in shorting CNO Financial Group shares can be evaluated.
CNO Financial Group's "short interest ratio" (SIR) is the quantity of CNO Financial Group shares currently shorted divided by the average quantity of CNO Financial Group shares traded daily (recently around 766048.19004525). CNO Financial Group's SIR currently stands at 4.42. In other words for every 100,000 CNO Financial Group shares traded daily on the market, roughly 4420 shares are currently held short.
However CNO Financial Group's short interest can also be evaluated against the total number of CNO Financial Group shares, or, against the total number of tradable CNO Financial Group shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case CNO Financial Group's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 CNO Financial Group shares in existence, roughly 20 shares are currently held short) or 0.033% of the tradable shares (for every 100,000 tradable CNO Financial Group shares, roughly 33 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against CNO Financial Group.
Find out more about how you can short CNO Financial Group stock.
Dividend payout ratio: 20.25% of net profits
Recently CNO Financial Group has paid out, on average, around 20.25% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.97% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), CNO Financial Group shareholders could enjoy a 1.97% return on their shares, in the form of dividend payments. In CNO Financial Group's case, that would currently equate to about $0.46 per share.
While CNO Financial Group's payout ratio might seem low, this can signify that CNO Financial Group is investing more in its future growth.
CNO Financial Group's most recent dividend payout was on 24 March 2021. The latest dividend was paid out to all shareholders who bought their shares by 9 March 2021 (the "ex-dividend date").
CNO Financial Group's shares were split on a 2:1 basis on 12 February 1997. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your CNO Financial Group shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for CNO Financial Group shares which in turn could have impacted CNO Financial Group's share price.
Over the last 12 months, CNO Financial Group's shares have ranged in value from as little as $8.6215 up to $24.68. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while CNO Financial Group's is 1.4248. This would suggest that CNO Financial Group's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
CNO Financial Group, Inc., through its subsidiaries, develops, markets, and administers health insurance, annuity, individual life insurance, and other insurance products for senior and middle-income markets in the United States. It operates through Bankers Life, Washington National, Colonial Penn, and Long-Term Care in Run Off segments. The company's Bankers Life segment underwrites, markets, and distributes Medicare supplement insurance, interest-sensitive and traditional life insurance, fixed annuities, and long-term care insurance products; and Medicare advantage and prescription drug plan products through various distribution and marketing agreements. Its Washington National segment underwrites, markets, and distributes supplemental health insurance, including specified disease, accident, and hospital indemnity insurance products; and life insurance at home and the worksite through independent marketing organizations and insurance agencies. The company's Colonial Penn segment primarily markets graded benefit and simplified issue life insurance directly to customers through television advertising, direct mail, the internet, and telemarketing. Its Long-Term Care in Run Off segment engages in the long-term care business. The company sells its products through career agents, independent producers, and direct marketing. CNO Financial Group, Inc. was founded in 1979 and is headquartered in Carmel, Indiana.
Everything we know about the Toast Inc IPO, plus information on how to buy in.
Everything we know about the Cyxtera IPO, plus information on how to buy in.
Everything we know about the ATI Physical Therapy IPO, plus information on how to buy in.
Everything we know about the Sportradar IPO, plus information on how to buy in.
Everything we know about the Longboard Pharmaceuticals Inc IPO, plus information on how to buy in.
Everything we know about the Prometheus Biosciences Inc IPO, plus information on how to buy in.
Everything we know about the Olo Inc IPO, plus information on how to buy in.
Everything we know about the China Eco-Materials Group Co Limited IPO, plus information on how to buy in.
Everything we know about the Gain Therapeutics Inc IPO, plus information on how to buy in.
Everything we know about the Karat Packaging Inc IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.